Last reviewed · How we verify
NCT03368885
Evaluation of Integrating MIYCN Interventions in Existing CGPP of PCI
NA trial testing Maternal dietary diversity in Polio in 2,590 participants. Completed in 24 December 2018.
24 December 2018
Quick facts
| Lead sponsor | FHI 360 |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 2,590 |
| Start date | 1 December 2017 |
| Primary completion | 24 December 2018 |
| Estimated completion | 24 December 2018 |
| Sites | 1 location across India |
Drugs / interventions tested
- Maternal dietary diversity
- Diet diversity in complementary feeding
- Exclusive Breast Feeding
- Community mobilization
- Capacity Building
- Use of existing platforms VHSND
- Strategic use of data
Conditions studied
- Polio — all drugs for Polio →
Sponsor
FHI 360 — full company profile →
Who can join
Adults 15 to 49, female only, with Polio. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study has two arms; both experimental and control areas will receive standard interventions given under polio eradication program of PCI. Participants in the experimental arm receive additional interventions on nutrition (improve diet diversity in pregnant women and children of 6-23 months) for exact 12 months. The study includes awareness generation (regarding nutrition) through community mobilization, counseling and capacity building of community mobilization.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03368885
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Polio
Currently open trials in the same condition.
- NCT06218368 — A Tool Kit to Improve Vaccine Confidence in the Philippines · NA · active not recruiting
Other FHI 360 trials
Trials by the same sponsor.
- NCT05233956 — Levonorgestrel Intrauterine System Effects on Hemoglobin and Serum Ferritin Among Anemic Women in Kenya · NA · active not recruiting
- NCT05937698 — The CATALYST Study · terminated
- NCT05889533 — Eswatini Ring Study: Increasing PrEP Options for Women · terminated
- NCT05016895 — REACH2: Implementation Research on Bi-Annual Mass Distribution of Azithromycin to Children 1-11 Months in Côte d'Ivoire · NA · completed
- NCT04617626 — Resiliency Through Azithromycin for Children (REACH), Côte d'Ivoire · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03368885 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by FHI 360
- Last refreshed: 1 May 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03368885.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing